These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30145662)

  • 1. Dental management of patient with dual antiplatelet therapy: a meta-analysis.
    Li L; Zhang W; Yang Y; Zhao L; Zhou X; Zhang J
    Clin Oral Investig; 2019 Apr; 23(4):1615-1623. PubMed ID: 30145662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
    Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of bleeding after minor oral surgery in patients on dual antiplatelet therapy: a systematic review and meta-analysis.
    Ockerman A; Bornstein MM; Leung YY; Li SKY; Politis C; Jacobs R
    Int J Oral Maxillofac Surg; 2020 Jan; 49(1):90-98. PubMed ID: 31248706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual antiplatelet therapy after coronary artery bypass surgery: is there an increase in bleeding risk? A meta-analysis.
    Zhao Y; Peng H; Li X; Qin Y; Cao F; Peng D; Liu J
    Interact Cardiovasc Thorac Surg; 2018 Apr; 26(4):573-582. PubMed ID: 29237042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Qin T; Chen MH
    BMC Cardiovasc Disord; 2015 Oct; 15():118. PubMed ID: 26450578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials.
    Wang W; Liu J; Fang J; Liu Y; An T; Zou M; Cheng G
    Int J Cardiol; 2017 May; 235():73-86. PubMed ID: 28284499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of randomized controlled trials.
    Fei Y; Tsoi MF; Cheung TT; Cheung BM
    Int J Cardiol; 2016 Oct; 220():895-900. PubMed ID: 27400191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Evidence for Dual Antiplatelet Therapy after Endovascular Arterial Procedures: A Meta-analysis.
    Peeters Weem SM; van Haelst ST; den Ruijter HM; Moll FL; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):253-62. PubMed ID: 27241270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of short-term dual- versus mono-antiplatelet therapy in patients with ischemic stroke or TIA: a meta-analysis of 10 randomized controlled trials.
    Liu Y; Fei Z; Wang W; Fang J; Zou M; Cheng G
    J Neurol; 2016 Nov; 263(11):2247-2259. PubMed ID: 27541045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Bavishi C; Trivedi V; Singh M; Katz E; Messerli FH; Bangalore S
    Am J Med; 2017 Nov; 130(11):1325.e1-1325.e12. PubMed ID: 28623176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials.
    Abo-Salem E; Alsidawi S; Jamali H; Effat M; Helmy T
    Cardiovasc Ther; 2015 Oct; 33(5):253-63. PubMed ID: 26010419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients.
    Savarese G; Savonitto S; Lund LH; Paolillo S; Marciano C; Dellegrottaglie S; Parente A; Trimarco B; Luscher TF; Perrone-Filardi P
    Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):218-28. PubMed ID: 27533949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.
    Navarese EP; Andreotti F; Schulze V; Kołodziejczak M; Buffon A; Brouwer M; Costa F; Kowalewski M; Parati G; Lip GY; Kelm M; Valgimigli M
    BMJ; 2015 Apr; 350():h1618. PubMed ID: 25883067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials.
    Verma S; Goodman SG; Mehta SR; Latter DA; Ruel M; Gupta M; Yanagawa B; Al-Omran M; Gupta N; Teoh H; Friedrich JO
    BMC Surg; 2015 Oct; 15():112. PubMed ID: 26467661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.
    Ziada KM; Abdel-Latif AK; Charnigo R; Moliterno DJ
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):722-732. PubMed ID: 26309050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
    Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.
    Palmerini T; Benedetto U; Bacchi-Reggiani L; Della Riva D; Biondi-Zoccai G; Feres F; Abizaid A; Hong MK; Kim BK; Jang Y; Kim HS; Park KW; Genereux P; Bhatt DL; Orlandi C; De Servi S; Petrou M; Rapezzi C; Stone GW
    Lancet; 2015 Jun; 385(9985):2371-82. PubMed ID: 25777667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis.
    Liu L; Huang J; Zhang X; Tang X
    PLoS One; 2018; 13(6):e0199232. PubMed ID: 29920547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.